Rapid detection of COVID-19 and its variants : vimarsana.com

Rapid detection of COVID-19 and its variants


Ontario-based, Nicoya Lifesciences, is in the process of completing a prototype of a low-cost, single-use device that tests for active SARS-CoV-2 infection, variants and, eventually, other viruses. The novel test is called Atlas.
Users administer the Atlas test themselves with a simple saliva collection kit. After that, a smartphone application provides results, in only 20 minutes – without complex lab equipment or highly trained technicians. 
Atlas was developed with funding from the National Research Council of Canada (NRC) as part of a joint challenge issued with the Public Health Agency of Canada (PHAC) through the government’s Innovative Solutions Canada (ISC) program.

Related Keywords

Canada , Canadian , Bryan Denomme , Nicoya Lifesciences , Public Health Agency Of Canada , Canada Industrial Research Assistance Program , National Research Council Of Canada , Innovative Solutions Canada , National Research Council , Public Health Agency , Industrial Research Assistance Program , Downstream Processing , Covid 19 , Pipelines , Analytical Technologies Amp Services , Iagnostics , Variants , Testing , கனடா , கனடியன் , நிகோயா ஆயுள் அறிவியல் , கனடா தொழில்துறை ஆராய்ச்சி உதவி ப்ரோக்ர்யாம் , தேசிய ஆராய்ச்சி சபை ஆஃப் கனடா , புதுமையானது தீர்வுகள் கனடா , தேசிய ஆராய்ச்சி சபை , தொழில்துறை ஆராய்ச்சி உதவி ப்ரோக்ர்யாம் , கீழ்நிலை ப்ரோஸெஸிஂக் , விட் ,

© 2025 Vimarsana